Current partner codePEPTIDESDE
Evidence dashboardStudies since 2008Updated Jul 31, 2026

IpamorelinClinical Trials.

A source-linked view of every Ipamorelin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials
3
Recruiting
0
Completed
2
Terminated
0
Results posted
0
Average enrollment
219
Countries
1
Highest phase
Phase 2

Developer / research origin

Novo Nordisk

Evidence summary

Activity is not efficacy.

Ipamorelin appears in 3 indexed studies: 0 recruiting, 2 completed and 0 with registry results posted. The highest registered development stage in this snapshot is Phase 2. These counts measure registry activity; they do not establish that Ipamorelin is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

20082022

Velocity

Ipamorelin studies by start year

Study start year · indexed snapshot

1110020082008: 1 trials2009: 0 trials2010: 0 trials20112011: 1 trials2012: 0 trials2013: 0 trials20142014: 0 trials2015: 0 trials2016: 0 trials20172017: 0 trials2018: 0 trials2019: 0 trials20202020: 0 trials2021: 0 trials20222022: 1 trials

Development

Trials by phase

Early Phase 10
Phase 10
Phase 22
Phase 30
Phase 40

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

NCT07717866

Trifecta Research Study

Axial Therapeutic Research · PTSD - Post Traumatic Stress Disorder · Cognitive Dysfunction

Not applicable

Active, not recruiting

52

2026-07

No studies in this snapshot.

Full study index

Search Ipamorelin trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

3 matching studies

End of 3 results